A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations with Dexamethasone plus Carfilzomib,
Dexamethasone plus Daratumumab, and Dexamethasone plus Pomalidomide in Multiple Myeloma
A Phase 1b/2 Study of BGB-11417 in Monotherapy and in Various Combinations with Dexamethasone plus Carfilzomib,
Dexamethasone plus Daratumumab, and Dexamethasone plus Pomalidomide in Multiple Myeloma